Humana (HUM) Common Equity (2009 - 2026)

Humana (HUM) has reported Common Equity for 18 consecutive years, with $19.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity rose 5.37% year-over-year to $19.3 billion in Q2 2026; TTM through Jun 2026 was $19.3 billion, a 5.37% increase from a year earlier, with the FY2025 full-year figure at $17.7 billion, up 7.86% from the prior year.
• Common Equity was $19.3 billion for Q2 2026 at Humana, up from $18.6 billion in the prior quarter.
• Over five years, Common Equity peaked at $19.3 billion in Q2 2026 and troughed at $15.3 billion in Q1 2022.
• A 5-year average of $17.0 billion and a median of $16.8 billion in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity retreated 4.55% in 2022 and rose 10.09% in 2025, its largest moves.
• Over 5 years, Common Equity stood at $15.4 billion in 2022, then rose by 6.17% to $16.3 billion in 2023, then gained by 0.78% to $16.4 billion in 2024, then increased by 7.86% to $17.7 billion in 2025, then climbed by 8.68% to $19.3 billion in 2026.
• The last three Common Equity figures came in at $19.3 billion (Q2 2026), $18.6 billion (Q1 2026), and $17.7 billion (Q4 2025), per Business Quant data.